Toby C. Campbell, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Toby C. Campbell, MD is a member of the University of Wisconsin Carbone Cancer Center as an associate professor of medicine within the hematology-oncology section of the UW School of Medicine and Public Health as well as chief of the Palliative Care program and program director of the Palliative Care fellowship training program. Dr. Campbell received his medical degree from the University of Virginia and completed his internal medicine residency at the University of Wisconsin Hospital and Clinics. He recently completed fellowships in medical oncology and palliative medicine at Northwestern University.
Dr. Campbell's clinical practice interests are in Lung Cancer, symptom management, communication and Palliative Care. His clinical research interests are in lung cancer therapeutics, chemotherapy-induced peripheral neuropathy, symptom management, and interdisciplinary medical teams. He is a member of the American Society of Clinical Oncology, American Association of Hospice and Palliative Medicine and the American Association for the Physician and Patient.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Medicine|
Professional Certifications and Education
Hospice and Palliative Medicine
University of Wisconsin Hospital and Clinics, Madison, WI
University of Virginia School of Medicine, Charlottesville, VA, 2001
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Programs & Conditions
Dr. Campbell is part of the Lung Disease-Oriented Working Group, through which multiple clinical trials in lung cancer are helping to find better treatments for those with cancer. His research interest is lung cancer therapeutics, including early phase clinical trials, and the management of chemotherapy-induced peripheral neuropathy.
Kruser JM Taylor LJ Campbell TC Zelenski A Johnson SK Nabozny MJ Steffens NM Tucholka JL Kwekkeboom KL Schwarze ML .
"Best Case/Worst Case": Training surgeons to use a novel communication tool for high-risk acute surgical problems. J Pain Symptom Manage. 2017 Jan 3;
[PubMed ID: 28062349]
Paice JA Portenoy R Lacchetti C Campbell T Cheville A Citron M Constine LS Cooper A Glare P Keefe F Koyyalagunta L Levy M Miaskowski C Otis-Green S Sloan P Bruera E .
Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 Sep 20;34(27):3325-45
[PubMed ID: 27458286]
Schehr JL Schultz ZD Warrick JW Guckenberger DJ Pezzi HM Sperger JM Heninger E Saeed A Leal T Mattox K Traynor AM Campbell TC Berry SM Beebe DJ Lang JM .
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1. PLoS One. 2016 Jul 26;11(7):e0159397
[PubMed ID: 27459545]
Vidaver RM Shershneva MB Hetzel SJ Holden TR Campbell TC .
Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study. J Oncol Pract. 2016 Jun;12(6):e643-53
[PubMed ID: 27143146]
King JD Eickhoff J Traynor A Campbell TC .
Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review. J Pain Symptom Manage. 2016 Jun;51(6):1027-32
[PubMed ID: 26948411]
Kamal AH Anderson WG Boss RD Brody AA Campbell TC Creutzfeldt CJ Hurd CJ Kinderman AL Lindenberger EC Reinke LF .
The Cambia Sojourns Scholars Leadership Program: Project Summaries from the Inaugural Scholar Cohort. J Palliat Med. 2016 Jun;19(6):591-600
[PubMed ID: 27168030]
Thraen-Borowski KM Gennuso KP Ganganon R Trentham-Dietz A Koltyn KF Adams AK Campbell T Colbert LH .
Impact Of Exercise On Prognosis, Quality Of Life, And Exercise Capacity In Lung Cancer Survivors: 1882 Board #34 June 2, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):517
[PubMed ID: 27360707]
Rocque GB Mullvain JA Eickhoff J Cleary JF Campbell TC .
Integrating palliative care into the oncology clinic: A joint management approach. Palliat Med. 2016 May;30(5):510-2
[PubMed ID: 26338850]
Schwarze ML Campbell TC Cunningham TV White DB Arnold RM .
You Can't Get What You Want: Innovation for End-of-Life Communication in the Intensive Care Unit. Am J Respir Crit Care Med. 2016 Jan 1;193(1):14-6
[PubMed ID: 26474354]
Nabozny MJ Kruser JM Steffens NM Brasel KJ Campbell TC Gaines ME Schwarze ML .
Constructing High-stakes Surgical Decisions: It's Better to Die Trying. Ann Surg. 2016 Jan;263(1):64-70
[PubMed ID: 25563878]
Braus N Campbell TC Kwekkeboom KL Ferguson S Harvey C Krupp AE Lohmeier T Repplinger MD Westergaard RP Jacobs EA Roberts KF Ehlenbach WJ .
Prospective study of a proactive palliative care rounding intervention in a medical ICU. Intensive Care Med. 2016 Jan;42(1):54-62
[PubMed ID: 26556622]
Maynard DW Cortez D Campbell TC .
'End of life' conversations, appreciation sequences, and the interaction order in cancer clinics. Patient Educ Couns. 2016 Jan;99(1):92-100
[PubMed ID: 26299872]
Campbell TC .
A PIECE OF MY MIND. When Minutes Matter. JAMA. 2015 Nov 3;314(17):1799-800
[PubMed ID: 26529156]
Rocque GB Campbell TC Johnson SK King J Zander MR Quale RM Eickhoff JC Cleary JF .
A Quantitative Study of Triggered Palliative Care Consultation for Hospitalized Patients With Advanced Cancer. J Pain Symptom Manage. 2015 Oct;50(4):462-9
[PubMed ID: 26087471]
Kruser JM Nabozny MJ Steffens NM Brasel KJ Campbell TC Gaines ME Schwarze ML .
"Best Case/Worst Case": Qualitative Evaluation of a Novel Communication Tool for Difficult in-the-Moment Surgical Decisions. J Am Geriatr Soc. 2015 Sep;63(9):1805-11
[PubMed ID: 26280462]
Mullvain JA Kozak KR Moody JS Campbell TC .
Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life. Support Care Cancer. 2015 Sep;23(9):2643-8
[PubMed ID: 25663509]
Holden TR Smith MA Bartels CM Campbell TC Yu M Kind AJ .
Hospice Enrollment, Local Hospice Utilization Patterns, and Rehospitalization in Medicare Patients. J Palliat Med. 2015 Jul;18(7):601-12
[PubMed ID: 25879990]
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S .
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Kruser TJ McCabe BP Mehta MP Khuntia D Campbell TC Geye HM Cannon GM .
Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma. Am J Clin Oncol. 2014 Feb;37(1):70-6
[PubMed ID: 23357968]
Hoang T Campbell TC Zhang C Kim K Kolesar JM Oettel KR Blank JH Robinson EG Ahuja HG Kirschling RJ Johnson PH Huie MS Wims ME Larson MM Hernan HR Traynor AM .
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study. Invest New Drugs. 2014 Feb;32(1):195-9
[PubMed ID: 23728919]